Beta interferon drug for Multiple Sclerosis

 

Prof. Michel Revel spent more than 30 years studying interferons, which play a key role in the immune system. In the late 1970s, he isolated the interferon-beta gene and designed several methods for producing the interferon-beta protein.

 

 

Beta interferon, a drug that alleviates certain symptoms of multiple sclerosis, is produced on the basis of Revel’s research. It is manufactured by InterPharm Laboratories Ltd. in Kiryat Weizmann under the name Rebif®.